Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science

Troy Seidle; Helena Kandarova; Thomas Hartung; Marcel Leist; Winfried Neuhaus; Horst Spielmann; Costanza Rovida

doi:10.14573/altex.2110271

pdf

Published: Jan 12, 2022

DOI: https://doi.org/10.14573/altex.2110271

Troy Seidle

Humane Society International/Europe, Brussels, Belgium

Helena Kandarova

European Society of Toxicology In Vitro (ESTIV), Houten, The Netherlands; Slovak National Platform for 3Rs, Bratislava, Slovakia; Centre of Experimental Medicine SAS, Slovak Academy of Sciences, Bratislava, Slovakia

Thomas Hartung

Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Bloomberg School of Public Health, Environmental Health and Engineering, Doerenkamp-Zbinden Chair for Evidence-based Toxicology, Baltimore, MD, USA; CAAT-Europe, University of Konstanz, Konstanz, Germany

https://orcid.org/0000-0003-1359-7689

Marcel Leist

Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Konstanz, Germany; In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany

http://orcid.org/0000-0002-3778-8693

Winfried Neuhaus

European Society for Alternatives to Animal Testing (EUSAAT), Luftenberg/Donau, Austria

Horst Spielmann

European Society for Alternatives to Animal Testing (EUSAAT), Luftenberg/Donau, Austria

Costanza Rovida

ecopa, Vosselaar, Belgium

How to Cite

Seidle, T., Kandarova, H., Hartung, T., Leist, M., Neuhaus, W., Spielmann, H. and Rovida, C. (2022) “Open letter: Selection of a new Executive Director of the European Chemicals Agency (ECHA) provides an opportunity for the EU to lead in the field of chemicals management and implementation of innovative science”, ALTEX - Alternatives to animal experimentation, 39(1), pp. 149–150. doi: 10.14573/altex.2110271.

Issue

Vol. 39 No. 1 (2022)

Section

Letter

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).

Most read articles by the same author(s)

Thomas Luechtefeld, Thomas Hartung, Computational approaches to chemical hazard assessment , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 4 (2017)
Dayna Kerecman Myers, Alan M. Goldberg, Albrecht Poth, Michael F. Wolf, Joseph Carraway, James McKim, Kelly P. Coleman, Richard Hutchinson, Ronald Brown, Harald F. Krug, Anthony Bahinski, Thomas Hartung, From in vivo to in vitro: The medical device testing paradigm shift , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 4 (2017)
Thomas Hartung, Thresholds of Toxicological Concern – Setting a threshold for testing below which there is little concern , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 3 (2017)
David Pamies, Paula Barreras, Katharina Block, Georgia Makri, Anupama Kumar, Daphne Wiersma, Lena Smirnova, Ce Zhang, Joseph Bressler, Kimberly M. Christian, Georgina Harris, Guo-li Ming, Cindy J. Berlinicke, Kelly Kyro, Hongjun Song, Carlos A. Pardo, Thomas Hartung, Helena T. Hogberg, A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 3 (2017)
Chiara Scanarotti, Costanza Rovida, Susanna Penco, Stefania Vernazza, Sara Tirendi, Rosagemma Ciliberti, Anna Maria Bassi, Alternative approach to animal testing and cell cultures, according to European laws , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 3 (2017)
Thomas Hartung, Food for Thought ... the first ten years , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 2 (2017)
Thomas Hartung, Opinion versus evidence for the need to move away from animal testing , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 2 (2017)
Ellen Fritsche, Kevin M. Crofton, Antonio F. Hernandez, Susanne Hougaard Bennekou, Marcel Leist, Anna Bal-Price, Elissa Reaves, Martin F. Wilks, Andrea Terron, Magdalini Sachana, Anne Gourmelon, OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 2 (2017)
Francois Busquet, Thomas Hartung, Corrigendum to The need for strategic development of safety sciences , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 2 (2017)
Francois Busquet, Thomas Hartung, The need for strategic development of safety sciences , ALTEX - Alternatives to animal experimentation: Vol. 34 No. 1 (2017)

1 2 3 4 5 6 7 8 9 10 > >>

Article Sidebar

Main Article Content

Article Details

Most read articles by the same author(s)